Interesting that UBS has recently increased its valuation on Acadia pharmaceuticals from $22 to $32 and talking about increasing Nuplazid and DAYBUE sales whereas less than 6 months ago they were talking down DAYBUE big time,and have been one of the largest sellers of Neu in the last 12 months .A very big 180 degree turnaround you would have to say!!!!
NEU Price at posting:
$14.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)